Based on the mechanism of PARP1-H2AX-BRCA1/2, recent study has focused on PARP1 as a possible therapeutic target for various human malignant tumors [1, 2], especially in carcinomas have defects in BRCA1/2 [9]. This evidence concerns the gene BRCA1 and cancer.